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Weaning phaseAbstract Background: Weaning from mechanical ventilation is a dynamic process inﬂuenced by
many factors. Volume guarantee is a new option within the patient-triggered modes of ventilation
and it can be best described as pressure-limited, continuous ﬂow ventilation with tidal volume
guidance or tidal volume targeting.
Objectives: The aim was to assess whether volume guarantee (VG) added before presumed window
time of 48 h pre-extubation can help to signiﬁcantly shorten this window in infants with respiratory
distress syndrome (RDS).
Patients and methods: This study was conducted at Al-Azhar University (Damietta, NICU of Pedi-
atric Department) in collaboration with Mansoura Faculty of Medicine, Egypt, between January
2012 and January 2013. Forty ventilated babies were randomly assigned during weaning phase
to either VG (group 1) (10 SIMV+ VG & 10 PSV + VG); or no VG group 2 (10 SIMV & 10
PSV). All babies were ventilated by Drager Babylog 8000 ventilator due to respiratory distress
syndrome (AC or SIMV as initial mode).
Results: Infants randomized to VG group achieved weaning success criteria faster than those ran-
domized to no VG group. Adding VG at the weaning phase resulted in more stable TV, a signiﬁcant
decrease in the mean airway pressure (MAP), oxygenation index, weaning duration, post extubation
NCPAP duration and extubation failure. No statistically signiﬁcant differences were observed in the
incidence of pneumothorax, patent ductus arteriosus (PDA), bronchopulmonary dysplasia (BPD),
weight gain and neonatal sepsis.
Conclusion: Volume guarantee seems to be both safe and effective in this group of patients.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Pediatric
Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Weaning from mechanical ventilation is a dynamic process and
is inﬂuenced, particularly in newborns, by many factors such
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underlying lung disease, secondary complications, unique
interaction of the neonatal heart and lungs, and the relation
between central control of respiratory drive and respiratory
muscles.1
Volume guarantee (VG) is a new option within the patient-
triggered modes of ventilation and it can be best described as
pressure-limited, continuous ﬂow ventilation with tidal volume
guidance or tidal volume targeting.2
It has been designed to combine the advantages of pressure-
limited ventilation with the advantages of volume-controlled
ventilation, without the inherent disadvantages of either of
these modalities when used on their own.3
It is intended to allow the clinician to make careful selection
of appropriate tidal volumes with which to ventilate the new-
born infant while retaining all of the considerable advantages
that pressure-limited ventilation affords. The aim is to provide
the newborn infant with, on average, much more stable
assisted tidal ventilation from breath to breath, free from the
perturbations in tidal volume that pressure-limited ventilation
alone produces.4
We hypothesized that the addition of VG before presumed
window time of 48 h pre-extubation may help to signiﬁcantly
shorten this window by adding more improvement in respira-
tory status and other outcome variables.
Aim of the work
The aim of this study was to assess whether volume guarantee
(VG) added before presumed window time of 48 h pre-
extubation can help to signiﬁcantly shorten this window by
adding more improvement in respiratory status and other
outcome variables in infants with respiratory distress
syndrome (RDS).Patients and methods
Study design and interventions
This randomized prospective trial was conducted at Al-Azhar
University (Damietta Faculty of Medicine, NICU of Pediatric
Department) in collaboration with Mansoura Faculty of
Medicine, NICU of Pediatric Department, Egypt, between
January 2012 and January 2013. The current study comprised
40 ventilated babies who were randomly assigned during weaning
phase to either VG group 1 (10 SIMV+ VG & 10 PSV
+ VG); or no VG group 2 (10 SIMV & 10 PSV). All babies
were ventilated by Drager Babylog 8000 ventilator due to
respiratory distress syndrome (AC or SIMV as initial mode)
evidenced by clinical and radiological criteria.Patients
Infants were deemed eligible if their gestational ages were
634 weeks and had respiratory distress syndrome to warrant
assisted mechanical ventilation within 72 h of delivery and they
were expected to be extubated within 48 h due to stable
blood gases & O2 saturation with low ventilatory parameters.
Babies with Endotracheal tube leakage >30% (as accurate
determination of tidal volumes may be compromised); majorcongenital anomalies; congenital heart disease; pneumothorax;
neonatal sepsis or meconium aspiration syndrome were
excluded.
Ventilation strategies
The initial modes of ventilation for all infants were A n C or
SIMV mode. However during weaning phase (48 h before
extubation) they were switched to VG group 1 (10 SIMV+
VG & 10PSV + VG) or no VG group 2 (10 SIMV & 10
PSV). In VG group the VT was set around 5 ml/kg and the
PIP limit was set at 15–20% above the average PIP needed to
achieve the target VT. In no VG group the PIP limit was set
to obtain TV around 5 ml/kg. The ventilator parameters were
decreased during the weaning phase guided by each infant’s
blood gases and clinical status .Our department protocol of
weaning is (FiO2 < 0.4, PIP 10–12 and or to achieve TV 5 ml/
kg, rate 6 20, PEEP 4–5 and ﬂow of 6–8 L/min). Blood gases’
analysis was measured at 1st and 4th hour after randomization,
and then at 4–6 h intervals or more often as needed.
Success outcome criteria for this trial consisted of arterial
blood pH 7.25–7.35, PaCO2 45–55 mmHg, PaO2 50–
70 mmHg, target FiO2 to maintain SpO2 88–95%, MAP<
8.0 cm H2O and oxygenation index <10. If successful
(>12 h) extubation occurred. Those babies were extubated
to NCPAP.
The reintubation criteria, extubation failure, were the same
in both groups, and included at least one of the following:
pH < 7.25 and PCO2 > 60 mmHg, SpO2 < 88% on FiO2 >
60%, more than two episodes of apnea/h (deﬁned as cessation
of breathing for 20 or <20 s if associated with cyanosis and/or
bradycardia) or any episode of apnea that did not respond to
tactile stimulation and required bag and mask ventilation.
Data acquisition and analysis
In this trial we compared the mean values of (FiO2, PIP, MAP,
TV and ABG) which were recorded at the start of the trial
(weaning phase), every 6 h during the trial, pre extubation
and post extubation. All infants were monitored using pulse
oximetry and blood pressure measurement.
Outcomes recorded in this trial were classiﬁed into Primary
outcomes (extubation failure, duration of weaning, post extu-
bation NCPAP duration death in hospital, oxygen at 28 days
(BPD)) and Secondary outcomes (failure of ventilatory mode,
pneumothorax, PDA, weight gain per week in grams, ventilation
and hospitalization days). Maternal and neonatal demographic
and clinical characteristics were also recorded.
Statistics
Data were entered, cleaned to identify inconsistencies and sta-
tistically analyzed using the Statistical Package for Social
Sciences (SPSS) version 16. Qualitative data were described
as numbers and percentages. v2 test or Fisher’s exact test was
used for comparison between the two groups, as appropriate.
Quantitative data were described as means (SD) or medians,
as appropriate. They were tested for normality. In the normally
distributed variables, independent sample t-test was used;
while in non-normally distributed variables, Mann–Whitney
test was used for comparison between the two groups.
Table 1 Demographic data and delivery room management.
VG (group 1) No VG (group 2) P value
Birth weight (g) 1239.3 ± 206.7 1213.9 ± 367.9 0.81 (NS)
Male/female 14/6 12/8 0.5 (NS)
Gestation (week) 30.9 ± 2.2 31.1 ± 2.1 0.82 (NS)
Antenatal steroids 6 (30.0%) 12 (60.0%) 0.63 (NS)
PROMa 4 (20.0%) 8 (40.0%) 0.16 (NS)
SGAb 5 (25.0%) 5 (25.0%) 1.0 (NS)
Neopuﬀ usage 12 (60.0%) 6 (30.0%) 0.63 (NS)
Surfactant administration 5 (25.0%) 3 (15.0%) 0.69 (NS)
a PROM= premature rupture of membrane.
b SGA= small for gestational age; NS: non-signiﬁcant.
Figure 1 Signiﬁcant decrease of the incidence of extubation
failure in VG group.
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Forty infants ventilated for RDS were included in the study.
During the weaning phase twenty infants were randomly
assigned to VG group 1 and the other twenty to no VG groupTable 2 Ventilatory parameters and blood gases’ data during the t
VG (group 1)
At the weaning phase
Ventilatory parameters
FiO2 33.6 ± 0.6
MAP 7.2 ± 0.6
TV 4.9 ± 0.3
Blood gases
pH 7.35 ± 0.07
PCO2 31.22 ± 9.0
PO2 90.91 ± 3.5
At extubation
Ventilatory parameters
FiO2 24.4 ± 5.3
MAP 5.6 ± 0.4
TV 5.0
Oxygenation index 6.29 ± 0.9
Blood gases
pH 7.36 ± 0.04
PCO2 43.4 ± 13.1
PO2 73.75 ± 13.1
* Signiﬁcant value; NS: non-signiﬁcant.2. There were no signiﬁcant difference between both groups as
regards birth weight, gestational age, infant risk, maternal risk,
neopuff usage or surfactant administration as seen in Table 1.
The comparative values of the mean FiO2, MAP, TV, pH,
PCO2 and PO2 at the weaning phase, extubation and post
extubation were recorded. MAP and O2 index were signiﬁ-
cantly lower in VG group. There was no signiﬁcant difference
of pre and post extubation blood gases (pH, PCO2 & PO2)
between both groups (P> 0.05) apart from pre-extubation
PCO2 which shows signiﬁcant decrease with VG group 2
(P< 0.05) (see Fig. 1 Table 2).
Many outcomes were recorded in both groups as seen in
Table 3. There was a signiﬁcant decrease in duration of wean-
ing and post-extubation NCPAP duration in VG group
(P< 0.05) (see Figs. 2 and 3). Moreover extubation failure
and hospitalization days were signiﬁcantly lower in VG. No
differences were observed in the incidence of PDA,
post-extubation pneumothorax, BPD and death.
Discussion
We conducted a prospective, randomized study to assess the
effect of combining volume guarantee mode with various
modes of ventilation during weaning of preterm infants withrial.
No VG (group 2) P value
32.2 ± 0.7 0.53 (NS)
7.3 ± 0.8 0.58 (NS)
4.0 ± 0.4 0.12 (NS)
7.35 ± 0.03 0.37 (NS)
35.46 ± 1.0 0.04*
86.88 ± 7.5 0.43 (NS)
26.2 ± 5.4 0.3 (NS)
6.1 ± 0.6 0.01*
5 1.0 (NS)
7.23 ± 1.4 0.02*
7.37 ± 0.35 0.36 (NS)
42.6 ± 3.8 0.62 (NS)
74.45 ± 17.0 0.88 (NS)
Table 3 Important outcomes of the studied patients.
VG (group 1) No VG (group 2) P value
Duration of weaning (h)
Median 14 24 0.02*
Minimum 12 14
Maximum 72 72
Days of post-extubation NCPAP
Median 1 2 0.02*
Minimum 0.25 0.25
Maximum 4 5
Extubation failure 1 (5.0%) 6 (30.0%) 0.04*
Days of ventilation 111.8 ± 32.9 112.1 ± 38.2 0.98 (NS)
Days of hospitalization 24.2 ± 5.1 30.1 ± 8.1 0.01*
PDA 3 (15.0%) 6 (30.0%) 0.46 (NS)
Post-extubation pneumothorax 2 (10.0%) 1 (5.0%) 0.89 (NS)
BPD 1 (5.0%) 2 (10.0%) 0.89 (NS)
Death 3 (15.0%) 3 (15.0%) 1.0 (NS)
* Signiﬁcant value; NS: non-signiﬁcant.
Volume guarantee ventilation in the weaning phase of preterm infants 89respiratory distress syndrome. Infants randomized to VG
group achieved weaning success criteria (arterial blood pH
(7.25–7.35), PaCO2 (45–55 mmHg), PaO2 (50–70 mmHg), tar-
get FiO2 to maintain SpO2 (88–95%), MAP< 8.0 cm H2O
and oxygenation index <10) faster than those randomized
to no VG group (weaning duration, median 14 h in VG group
versus median 24 h in no VG group) with P value<0.05. Adding
VG at the weaning phase resulted in a signiﬁcant decrease in
the MAP (5.6 ± 0.48 in VG group versus 6.1 ± 0.64 in no
VG group) and oxygenation index (6.29 ± 0.98 in VG group
versus 7.235 ± 1.44 in no VG group) which agree with previ-
ous trials (2, 5, 6, 7). This reduction was highest when VG was
combined with PSV.5
In our study, both groups were well-matched regarding
baseline clinical characteristics, birth weight, gestational age,
gender, weight for gestational age or maternal risk, resulting
in a non-signiﬁcant difference between both groups. Presence
of fetal or maternal may be related to RDS severity and
prognosis.6–9
In our study tidal volume is 5 ml/kg in both groups
matched with10–13 who recommend starting VG ventilation
with set TV of 4–6 ml/kg. As regards to blood gases’ courseFigure 2 Signiﬁcant decrease of duration of weaning in VG
group.during our trial (pH, PCO2 & PO2) there was no signiﬁcant
difference between both groups, apart from pre-extubation
PCO2 (31.28 ± 2.9) which showed signiﬁcant decrease with VG
group (P< 0.05) due to hyperventilation occurred when the
ventilator is triggered with every spontaneous breath especially
in infants with strong respiratory drive near extubation, this
was in agreement with.14,15 Our result was not in agreement
with2 who reported that PaCO2 was signiﬁcantly higher in
the VG group.
In the present study we found that adding VG during wean-
ing phase leads to a signiﬁcant reduction of MAP, oxygenation
index, weaning duration and post extubation NCPAP dura-
tion. These results are in agreement with a meta-analysis of
12 randomized trials with a total of 793 preterm infants.17
Only three of these trials were primarily designed to compare
the efﬁcacy and safety of VG and conventional modes in
RDS treatment.2,4,18 The combined outcome of death or
BPD was included in four trials.4,11,19,20
No individual trial reported a difference in the combined
outcome of death or BPD, but the pooled meta-analysis
revealed a reduction in this combined outcome. Recently two
long term trials were conducted7,21 and recorded a signiﬁcant
reduction of BPD in VG group. Our study is a short term
study (48 h before extubation) unlike other short term studies
(20 min to 4 h).3–5,7,16,17Figure 3 Signiﬁcant decrease of post-extubation NCPAP dura-
tion in VG group 1.
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group 2 with no signiﬁcant difference between both groups,
which may be attributed to the small sample size and short
interventional period.
One limitation of our study is the small sample size. With
the increased use of non-invasive ventilation techniques over
the last few years, the use of invasive mechanical ventilation
has decreased dramatically22 which is also the case in our prac-
tice as expected. The exclusion of babies who needed a shorter
duration of ventilation (i.e. <48 h) nor who developed sepsis,
which was proved bacteriologically; further reduced the
number of eligible patients for our study. The non-signiﬁcant
difference of BPD may be attributed to the small sample size.
Lake of tcPCO2 monitor, which measures minute to minute
PaCO2 leads to unavoidable low PaCO2 in some patients in
pre extubation period.
Conclusion
Our results support the ﬁndings of previous studies, which
demonstrated the reduction of PIP, MAP, oxygenation index
and tidal volume variability in VG group. However in our study
weaning duration, post extubation NCPAP duration and extu-
bation failure were recorded and showed signiﬁcant reduction
in the VG group. No statistically signiﬁcant differences were
observed in the incidence of pneumothorax, PDA, BPD, weight
gain and neonatal sepsis, but the number of cases of these issues
was lower and the duration of the trial was short.
Trials with a larger sample size are needed to derive sufﬁ-
cient power to examine differences in all outcomes. Further
investigations with different combined VG modes and differ-
ent tidal volumes are needed in order to derive more precise
instructions for clinical practice. Further studies and long term
follow up are needed to identify whether VTV modes improve
neurodevelopmental outcomes and to compare and reﬁne VTV
strategies.
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